1 | technology delivers fully individualized | | | | | | | 2 | 0.31% |
2 | outside of your country | | | | | | | 2 | 0.31% |
3 | and laser assisted surgery | | | | | | | 2 | 0.31% |
4 | phacoemulsification and laser assisted | | | | | | | 2 | 0.31% |
5 | may provide for different | | | | | | | 2 | 0.31% |
6 | which may provide for | | | | | | | 2 | 0.31% |
7 | states which may provide | | | | | | | 2 | 0.31% |
8 | equipment a versatile collection | | | | | | | 2 | 0.31% |
9 | deliver innovative solutions cataract | | | | | | | 2 | 0.31% |
10 | your country of residence | | | | | | | 2 | 0.31% |
11 | of your country of | | | | | | | 2 | 0.31% |
12 | countries outside of your | | | | | | | 2 | 0.31% |
13 | provide for different data | | | | | | | 2 | 0.31% |
14 | we disrupt the traditional | | | | | | | 2 | 0.31% |
15 | ophthalmology we disrupt the | | | | | | | 2 | 0.31% |
16 | in ophthalmology we disrupt | | | | | | | 2 | 0.31% |
17 | visit our virtual jj | | | | | | | 2 | 0.31% |
18 | our virtual jj vision | | | | | | | 2 | 0.31% |
19 | of vision after surgery | | | | | | | 2 | 0.31% |
20 | clinical medical and economics | | | | | | | 2 | 0.31% |
21 | treatment clinical medical and | | | | | | | 2 | 0.31% |
22 | equipment ocular surface care | | | | | | | 2 | 0.31% |
23 | laser assisted surgery that | | | | | | | 2 | 0.31% |
24 | johnsonjohnson surgical vision inc | | | | | | | 2 | 0.31% |
25 | refractive refractive equipment ocular | | | | | | | 2 | 0.31% |
26 | delivers fully individualized procedures | | | | | | | 2 | 0.31% |
27 | the quality of vision | | | | | | | 2 | 0.31% |
28 | improving the quality of | | | | | | | 2 | 0.31% |
29 | and improving the quality | | | | | | | 2 | 0.31% |
30 | gland dysfunction before cataract | | | | | | | 2 | 0.31% |
31 | meibomian gland dysfunction before | | | | | | | 2 | 0.31% |
32 | treating meibomian gland dysfunction | | | | | | | 2 | 0.31% |
33 | for treating meibomian gland | | | | | | | 2 | 0.31% |
34 | care for treating meibomian | | | | | | | 2 | 0.31% |
35 | fully individualized procedures ocular | | | | | | | 2 | 0.31% |
36 | eight million procedures our | | | | | | | 2 | 0.31% |
37 | protection rules than in | | | | | | | 2 | 0.31% |
38 | over eight million procedures | | | | | | | 2 | 0.31% |
39 | in over eight million | | | | | | | 2 | 0.31% |
40 | utilized in over eight | | | | | | | 2 | 0.31% |